科兴生物派发55美元特别股息，相当于停牌前股价8.5倍！

Group 1 - The core point of the news is that Kexing Bio has announced a special cash dividend of $55 per share, which is 8.5 times its stock price of $6.47 before suspension, and plans additional dividends of $19 and a potential third dividend ranging from $20 to $50 per share [1] - Kexing Bio's financial performance has shown significant cyclicality, with total profits of $240 million from 2015 to 2020, a peak net profit of $14.5 billion in 2021 due to the COVID-19 pandemic, and losses in 2023 and the first half of 2024, yet the board decided to implement a large-scale cash dividend plan reflecting substantial cash reserves accumulated during the pandemic [2] - The control dispute over Kexing Bio dates back to 2016, involving a legal battle between the actual controller Yin Weidong and former chairman Pan Aihua, leading to aggressive tactics such as power cuts and asset seizures, with a recent lawsuit from Weiw Capital claiming the board's actions are irresponsible and favoring certain shareholders [3]